(Q35089533)

6 August 2017

1 reference

title

Pathological and molecular aspects of prostate cancer (English)

1 reference

6 August 2017

1 reference

3

William B Isaacs

1 reference

6 August 2017

4

Jonathan I Epstein

1 reference

6 August 2017

Angelo M DeMarzo

1

1 reference

PubMed ID

12648986

6 August 2017

William G Nelson

series ordinal

2

1 reference

PubMed ID

12648986

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

361

1 reference

6 August 2017

955-964

1 reference

6 August 2017

9361

1 reference

Origin and development of carcinoma in the prostate

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Intraductal dysplasia: a premalignant lesion of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Microcarcinoma in the prostate: Its association with duct-acinar dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Molecular biology of prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Stage B adenocarcinoma of the prostate: transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

P504S: a new molecular marker for the detection of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Cytokeratin 34 beta E-12 immunoreactivity in benign prostatic acini. Quantitation, pattern assessment, and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

The dedifferentiation of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

De-differentiation with time in prostate cancer and the influence of treatment on the course of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Ability of sextant biopsies to predict radical prostatectomy stage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Single focus of adenocarcinoma in the prostate biopsy specimen is not predictive of the pathologic stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Pathologic assessment of the surgical specimen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Prostate cancer epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Hormones and prostate cancer: what's next?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Selenium, zinc, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Fat, meat, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Vegetables, fruits, associated micronutrients, and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Insulin-like growth factors and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Association of HPC2/ELAC2 genotypes and prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Analysis of the RNASEL gene in familial and sporadic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Role of macrophage scavenger receptors in response to Listeria monocytogenes infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Molecular epidemiology of hormone-metabolic loci in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Molecular genetics of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Roles for Nkx3.1 in prostate development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

KLF6, a candidate tumor suppressor gene mutated in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Preneoplastic prostate lesions: an opportunity for prostate cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Metastasis suppression in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

The development of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Targeting apoptosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

The polycomb group protein EZH2 is involved in progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912779-1

7 January 2021

10.1016/S0140-6736(03)12779-1

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12648986